1- Multidrug-Resistant Pathogen Surveillance in Pakistani and U.S. Hospitals
US partner: Gautam Dantas, Washington University
Pak partner: Saadia Andleeb, National University of Science and Technology, Islamabad
We successfully completed an initial 3-month sampling period of Intensive Care Unit (ICU) surfaces in Pakistan Hospitals and first 6-month sampling period for the US Hospital. Many species of bacteria that are commonly associated with hospital acquired infections have been isolated from surface samples in these rooms. Additionally, we have obtained fecal specimens from patients in the corresponding Pakistan and US ICUs. From fecal specimens from intensive care unit patients, multi-drug resistant bacterial pathogens were recovered. In total we have more than 700 bacterial isolates from ICU surfaces and more than 150 bacterial isolates from fecal specimens for additional characterization, including antimicrobial susceptibility testing and genomic analysis.